Summit Therapeutics (SMMT)
(Delayed Data from NSDQ)
$23.16 USD
-1.40 (-5.70%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $23.18 +0.02 (0.09%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.07 | 0.00% |
Earnings Summary
For their last quarter, Summit Therapeutics (SMMT) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.06 per share. This reflects a positive earnings surprise of 16.67%. Look out for SMMT's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.07 per share, reflecting a year-over-year decrease of 133.33%.
Earnings History
Price & Consensus
Zacks News for SMMT
Biotech Stock Roundup: TERN, SMMT Stocks Surge on Study Data, GSK's Vaccine Study Fails & More
SMMT: What are Zacks experts saying now?
Zacks Private Portfolio Services